Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1245.50

-24.30 (-1.91%)

< Home < Back

Dr. Reddy’s Laboratories submits press release

Date: 03-07-2019

Dr. Reddy’s Laboratories has informed about submission of a press release on ‘Dr. Reddy's Laboratories announces first-to-market launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (lmL) Single-dose Vial in the US Market’.

The above information is a part of company’s filings submitted to BSE.